- Investing Ideas
- Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
13
Mid-Large Cap Stocks
13 companies
Roche Holding
Market Cap: CHF 270.1b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 338.80
7D
6.3%
1Y
31.1%
Novartis
Market Cap: CHF 231.0b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 126.20
7D
4.9%
1Y
31.2%
Tecan Group
Market Cap: CHF 2.0b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 163.00
7D
8.4%
1Y
0.7%
Bachem Holding
Market Cap: CHF 5.5b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 72.90
7D
9.0%
1Y
25.7%
Cosmo
Market Cap: CHF 1.1b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 66.70
7D
-0.1%
1Y
17.2%
Sandoz Group
Market Cap: CHF 31.7b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 73.20
7D
5.4%
1Y
68.6%
SKAN Group
Market Cap: CHF 1.2b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 54.70
7D
12.0%
1Y
-23.6%
Galderma Group
Market Cap: CHF 43.6b
Operates as a dermatology company worldwide.
GALD
CHF 185.80
7D
7.0%
1Y
61.6%
Lonza Group
Market Cap: CHF 37.7b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 539.60
7D
7.8%
1Y
-4.5%
Dottikon ES Holding
Market Cap: CHF 3.8b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries.
DESN
CHF 272.00
7D
-4.9%
1Y
-11.0%
Idorsia
Market Cap: CHF 1.8b
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 6.89
7D
19.4%
1Y
220.5%
Siegfried Holding
Market Cap: CHF 3.1b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 69.90
7D
2.0%
1Y
-21.7%
PolyPeptide Group
Market Cap: CHF 1.5b
Operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally.
PPGN
CHF 45.55
7D
17.5%
1Y
126.1%